Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy ABVC Biopharma stock
Learn how to easily invest in ABVC Biopharma stock.
California biopharmaceutical company ABVC Biopharma, a company focused on drug and medical device development, is expected to conduct a public offering of units comprised of one share of common stock and one series A warrant each. The company, which is currently listed on the Over-the-Counter Markets under the ticker symbol "ABVC," has applied for listing on the Nasdaq. The offering of units is contingent upon Nasdaq approving this listing. If approved, ABVC's stock will trade under the ticker symbol "ABVC."
How to buy shares in ABVC Biopharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ABVC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ABVC Biopharma stock price (NASDAQ: ABVC)Use our graph to track the performance of ABVC stocks over time.
ABVC Biopharma shares at a glance
|Latest market close||$0.88|
|52-week range||$0.50 - $6.03|
|50-day moving average||$0.82|
|200-day moving average||$2.00|
|Wall St. target price||$3.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.67|
Buy ABVC Biopharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ABVC Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ABVC Biopharma price performance over time
|1 week (2022-09-23)||-3.67%|
|1 month (2022-09-02)||-13.73%|
|3 months (2022-07-01)||-12.87%|
|6 months (2022-03-30)||-68.90%|
|1 year (2021-09-28)||N/A|
|2 years (2020-10-02)||-78.54%|
|3 years (2019-10-02)||7.18|
|5 years (2017-09-28)||N/A|
ABVC Biopharma financials
|Gross profit TTM||$350,711|
|Return on assets TTM||-91.76%|
|Return on equity TTM||-346.98%|
|Market capitalisation||$29.8 million|
TTM: trailing 12 months
ABVC Biopharma share dividends
We're not expecting ABVC Biopharma to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (3.63% forward annual dividend yield)
- Bristol-Myers Squibb Company (BMY.US) (3.05% forward annual dividend yield)
- Johnson-and-Johnson (JNJ.US) (2.71% forward annual dividend yield)
Have ABVC Biopharma's shares ever split?
ABVC Biopharma's shares were split on a 1:18 basis on 8 May 2019. So if you had owned 18 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ABVC Biopharma shares – just the quantity. However, indirectly, the new 1700% higher share price could have impacted the market appetite for ABVC Biopharma shares which in turn could have impacted ABVC Biopharma's share price.
ABVC Biopharma share price volatility
Over the last 12 months, ABVC Biopharma's shares have ranged in value from as little as $0.5 up to $6.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ABVC Biopharma's is 0.3036. This would suggest that ABVC Biopharma's shares are less volatile than average (for this exchange).
To put ABVC Biopharma's beta into context you can compare it against those of similar companies.
- Pfizer (PFE.US): 0.654
- Bristol-Myers Squibb Company (BMY.US): 0.4227
- Johnson-and-Johnson (JNJ.US): 0.6065
ABVC Biopharma overview
ABVC BioPharma, Inc. , a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.
ABVC Biopharma in the news
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Study Update and Announces UCSF Institutional Review Board Approval
ABVC Biopharma Announces Letter to Shareholders
ABVC BioPharma Selects Additional Vitargus® Phase II Study Site
Frequently asked questionsWhat percentage of ABVC Biopharma is owned by insiders or institutions?
Currently 40.302% of ABVC Biopharma shares are held by insiders and 4.789% by institutions. How many people work for ABVC Biopharma?
Latest data suggests 28 work at ABVC Biopharma. When does the fiscal year end for ABVC Biopharma?
ABVC Biopharma's fiscal year ends in December. Where is ABVC Biopharma based?
ABVC Biopharma's address is: 44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538 What is ABVC Biopharma's ISIN number?
ABVC Biopharma's international securities identification number is: US00091F1066
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert